- Home
- JOF vs TVGN Comparison
JOF vs TVGN Comparison
Compare JOF & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOF
- TVGN
- Stock Information
- Founded
- JOF 1990
- TVGN 2020
- Country
- JOF Japan
- TVGN United States
- Employees
- JOF N/A
- TVGN N/A
- Industry
- JOF Trusts Except Educational Religious and Charitable
- TVGN Blank Checks
- Sector
- JOF Finance
- TVGN Finance
- Exchange
- JOF Nasdaq
- TVGN Nasdaq
- Market Cap
- JOF 234.0M
- TVGN 222.3M
- IPO Year
- JOF N/A
- TVGN N/A
- Fundamental
- Price
- JOF $8.27
- TVGN $1.09
- Analyst Decision
- JOF
- TVGN Strong Buy
- Analyst Count
- JOF 0
- TVGN 1
- Target Price
- JOF N/A
- TVGN $10.00
- AVG Volume (30 Days)
- JOF 43.9K
- TVGN 427.0K
- Earning Date
- JOF 01-01-0001
- TVGN 05-28-2025
- Dividend Yield
- JOF 3.33%
- TVGN N/A
- EPS Growth
- JOF N/A
- TVGN N/A
- EPS
- JOF N/A
- TVGN N/A
- Revenue
- JOF N/A
- TVGN N/A
- Revenue This Year
- JOF N/A
- TVGN N/A
- Revenue Next Year
- JOF N/A
- TVGN N/A
- P/E Ratio
- JOF N/A
- TVGN N/A
- Revenue Growth
- JOF N/A
- TVGN N/A
- 52 Week Low
- JOF $6.64
- TVGN $0.26
- 52 Week High
- JOF $8.04
- TVGN $4.78
- Technical
- Relative Strength Index (RSI)
- JOF 50.96
- TVGN 40.90
- Support Level
- JOF $8.36
- TVGN $1.13
- Resistance Level
- JOF $8.53
- TVGN $1.22
- Average True Range (ATR)
- JOF 0.10
- TVGN 0.07
- MACD
- JOF -0.02
- TVGN 0.00
- Stochastic Oscillator
- JOF 6.90
- TVGN 5.56
About JOF Japan Smaller Capitalization Fund Inc
Japan Smaller Capitalization Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.